Across TCGA cell cohorts, NR2F2 mutation is significantly associated with the drug of many other genes, with 5 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible NR2F2-associated genes across cancer lineages are OSU-03012, CAP-232, and Embelin. Each is linked with NR2F2 in more than 1 cancer types. Because this analysis shows association rather than direction, both NR2F2-to-partner and partner-to-NR2F2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NR2F2→partner) and Y-score (partner→NR2F2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	OSU-03012 →	+0.401	+2.889	.001	.025	3	1
BLOOD_Leukemia	CAP-232 →	+0.397	+2.922	.009	.024	2	1
BLOOD_Leukemia	Embelin →	+0.447	+3.055	.012	.019	1	1
BLOOD_Leukemia	XMD15-27 →	+0.323	+2.929	.030	.024	1	1
BLOOD_Leukemia	CMK →	+0.384	+2.889	.030	.025	1	1

Each partner links to its Q-omics profile. Showing the 5 strongest of 5 associations by consensus.

Exploration

NR2F2 survival (RNA) · tumor vs normal (RNA) · all NR2F2 data types